Chemoinformaics analysis of 4- methoxybenzaldehyde (2H4MB)
| Molecular Weight | 136.15 | nRot | 2 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 7 |
| Exact Molecular Weight | 136.052 | nRing | 1 |
| Solubility: LogS | -2 | nHRing | 0 |
| Solubility: LogP | 1.623 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 20.2983 |
| nHD | 0 | BPOL | 10.6297 |
| QED | 0.576 |
| Synth | 1.489 |
| Natural Product Likeliness | 0.082 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.005 |
| HIA | 0.009 |
| CACO-2 | -4.387 |
| MDCK | 0.0000148 |
| BBB | 0.988 |
| PPB | 0.796078 |
| VDSS | 1.034 |
| FU | 0.137117 |
| CYP1A2-inh | 0.955 |
| CYP1A2-sub | 0.789 |
| CYP2c19-inh | 0.472 |
| CYP2c19-sub | 0.612 |
| CYP2c9-inh | 0.055 |
| CYP2c9-sub | 0.851 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.842 |
| CYP3a4-inh | 0.04 |
| CYP3a4-sub | 0.341 |
| CL | 7.639 |
| T12 | 0.67 |
| hERG | 0.119 |
| Ames | 0.075 |
| ROA | 0.03 |
| SkinSen | 0.513 |
| Carcinogencity | 0.544 |
| EI | 0.995 |
| Respiratory | 0.937 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.891946 |